Novo Nordisk Launches Ozempic Oral Pill For Type 2 Diabetes
01 May 2026 //
PR NEWSWIRE
Mounjaro Sales Decline Due To Semaglutide Generics` Rise
10 Apr 2026 //
ECONOMICTIMES
Generic Drugmakers Rush As Novo Nordisk Loses Weight-Loss Drug
09 Apr 2026 //
ECONOMICTIMES
Experts Weigh Semaglutide Patent Expiry`s GLP-1 Impact
08 Apr 2026 //
PHARMABIZ
Novo Nordisk Plans To Cut Price Of Ozempic As Generics Hit Market
31 Mar 2026 //
ECONOMICTIMES
Weight Loss Drug Market Sees Surge From Pharma Companies
24 Mar 2026 //
ECONOMICTIMES
Novo To Track Generic Surge As Semaglutide Goes Off Patent
21 Mar 2026 //
ECONOMICTIMES
Natco Launches Rs 1,290 Semaglutide Following Novo Nordisk
20 Mar 2026 //
ECONOMICTIMES
Novo To Track Generic Surge As Semaglutide Goes Off Patent
20 Mar 2026 //
ECONOMICTIMES
Abbott Signs Pact With Novo Nordisk To Offer Semaglutide
28 Feb 2026 //
ECONOMICTIMES
Dr Reddy`s Readies Day-1 Launch Of Semaglutide Generic
18 Feb 2026 //
ECONOMICTIMES
Hims Quits On Obesity Pill After Legal, Regulatory Heat
09 Feb 2026 //
FIERCE PHARMA
Makary Criticizes `Illegal Copycat Drugs` Amid Hims` Compounded
06 Feb 2026 //
BIOSPACE
Hims & Hers Plans To Launch $49 Copy Of Wegovy Pill
05 Feb 2026 //
FIERCE PHARMA
SEC Recommends Three Firms For Semaglutide Formulations
19 Jan 2026 //
PHARMABIZ
HC Seeks Novo Nordisk`s Reply On Natco Plea To Revoke Patent
06 Jan 2026 //
ECONOMICTIMES
Intense Rivalry Between Lilly And Novo Opens Up India
24 Dec 2025 //
ECONOMICTIMES
HC OKs Dr. Reddy`s Semaglutide Exports, Bars Sales in India
03 Dec 2025 //
ECONOMICTIMES
Novo Nordisk Cuts Wegovy Prices, Generic Firms Adjust Pricing
27 Nov 2025 //
ECONOMICTIMES
Dr Reddy`s Gets Nod To Make Generic Semaglutide For Weight Loss
24 Oct 2025 //
ECONOMICTIMES
Novo`s Rybelsus Gains FDA Expansion To Reduce Risk Of MACE
21 Oct 2025 //
FIERCE PHARMA
Lupin Launches Liraglutide Injection In US
04 Oct 2025 //
INDPHARMAPOST
Indian Pharma Prepares For ?600-800 Cr Insulin Pen Market
22 Sep 2025 //
BUSINESS STD
Natco Pharma Sues Novo Nordisk Over Generic Drug Push
21 Aug 2025 //
ECONOMICTIMES
Dr Reddy`s Plan to Launch Generic of Novo`s Weight-Loss Drug
24 Jul 2025 //
REUTERS
ET Graphics: Tirzepatide, Semaglutide lead India, misuse concerns
16 Jul 2025 //
ECONOMICTIMES
India`s Biocon Drops Plan to Launch Weight-Loss Drugs in China
27 Jun 2025 //
REUTERS
Novo protects US patients with legal wins against compounder
25 Apr 2025 //
PR NEWSWIRE
Novo petitions FDA over Victoza compounding as generic win approval
06 Jan 2025 //
FIERCE PHARMA
Wegovy-maker Novo Nordisk to spend $4.1 bln to boost US manufacturing
25 Jun 2024 //
REUTERS
Teva launches generic version of Novo Nordisk`s diabetes drug Victoza
25 Jun 2024 //
REUTERS
Second Chinese drugmaker seeks approval for Ozempic generic
13 Jun 2024 //
REUTERS
Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China
06 Jun 2024 //
REUTERS
Chinese drugmakers developing generic drugs of Novo Nordisk`s Ozempic
05 Jun 2024 //
REUTERS
Novan Reports Top-Line Efficacy Results from Ph3 Trials of SB206
02 Jan 2020 //
PR NEWSWIRE
Novo Nordisk rolls out authorized insulin generics
07 Sep 2019 //
FIERCEPHARMA
Novo Nordisk and Mylan Battle Over Generic Versions of Victoza
23 Aug 2019 //
BIOSPACE
Novo plunks down $100M to ready plant for new-generation insulins
29 Mar 2019 //
FIERCE PHARMA
Will Novo and Sanofi follow Lilly`s generic Humalog move?
07 Mar 2019 //
FIERCE PHARMA
Insulin has become so expensive that this diabetic is trying to make his own
28 Jan 2019 //
CNBC
FDA Denies Novo Nordisk Petition on Liraglutide Generics
08 Jan 2018 //
RAPS

Market Place
Sourcing Support